Hana Turkova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 03, 2015
Biochemical Testing After Pheochromocytoma Removal: How Early?
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: July 16, 2015
Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension.
Journal: Journal of human hypertension
Published: November 19, 2014
Pheochromocytoma and markers of oxidative stress.
Journal: Physiological research
Published: March 16, 2013
Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice.
Journal: Endocrinology
Published: January 12, 2013
Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
Journal: Neoplasia (New York, N.Y.)
Published: December 17, 2012
Hereditary pheochromocytoma and paraganglioma
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 28, 2012
High incidence of cardiovascular complications in pheochromocytoma.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: April 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026